Cancer patients were severely harmed after being given years of unnecessary chemotherapy treatment by an NHS trust, a report has found.
Some people were misdiagnosed and given inappropriate courses of treatment, while others were incorrectly told that if they stopped chemotherapy they would die, according to a Royal College of Physicians (RCP) report.
The report on the treatment of brain tumour patients at University Hospitals Coventry and Warwickshire NHS trust was commissioned after concerns were raised by colleagues of Prof Ian Brown, a clinical oncologist, whose patients were handed over after his retirement in 2023.
They found that his patients were on long-term repeated cycles of the chemotherapy drug temozolomide (TMZ), which is far longer than the usual course of treatment, without evidence that continuing it would benefit them. Some of his patients had been left on treatment despite their cancer progressing, when moving to supportive care for their symptoms would have been a better choice.
The report examined the cases of 20 patients. Fifteen of these were found to have received unsatisfactory care and five cases were graded as requiring improvement.
One patient had more than 10 years of chemotherapy and was told they had deadly glioblastoma, according to the report. This was later found to be a grade-1 pilocytic astrocytoma, a low-grade tumour with potentially normal life expectancy that does not require chemotherapy.
Another patient had chemotherapy treatment for a decade and experienced “significant toxicity”, including fatigue, nausea, severe shingles requiring hospital admission, and nausea and vomiting.
Leaders at the trust have apologised for the failures. The legal firm Brabners, which is representing more than 40 patients, is calling for an independent public inquiry.
Source: The Guardian, 18 November 2026
Recommended Comments
Create an account or sign in to comment